Cureus, Journal Year: 2025, Volume and Issue: unknown
Published: March 2, 2025
Multiple sclerosis (MS) is a heterogeneous disease, and each MS patient exhibits different clinical symptoms that are reflected in their magnetic resonance imaging (MRI) results. Each lesion should be interpreted carefully evaluated conjunction with examination. MRI plays major role evaluating how lesions aggregated the central nervous system they change over time. There several conventional biomarkers of could utilized to evaluate phenotype. useful for decisions, aiding determination disease-modifying treatment or disease prognosis. Despite its higher sensitivity, provides low specificity due heterogeneity lesions. However, advanced show promise terms defining lesions, as biomarker correlates differently scenario The aim this review summarise current state brain relate neurological disabilities.
Language: Английский